Table 2 Comparison of our analyte concentrations to other publications (all µM ± S.D.). N/A is not available
Reference > Analyte | This work Baseline (n = 47) | Chu et al. [12] (n = 659) | Ibrahim et al. [13] (n = 54) | Clement et al. [14] (n = 10) | Seyedsadjadi et al. [15] (n = 100) | Galla et al. [16] (n = 10) |
|---|---|---|---|---|---|---|
Plasma Nicotinamide | 0.5 ± 0.1 | 0.9 ± 0.02 | 1.2 ± 0.14 | 38 ± 11 | 32 ± 11 | N/A |
Plasma methyl-nicotinamide | 0.14 ± 0.03 | 0.1 ± 0.002 | N/A | 0.05 ± 0.01 | 0.033 ± 0.012 | 0.185 ± 0.116 |
Plasma NAD+ | < 1.2 | N/A | N/A | 0.008 ± 0.02 | 0.023 ± 0.012 | N/A |
CSF Nicotinamide | < 0.4 | N/A | N/A | N/A | N/A | N/A |
CSF methyl-nicotinamide | < 0.1 | N/A | N/A | N/A | N/A | 0.039 ± 0.025 |